Younes A - Search Results

1

Current role of gemcitabine in the treatment of Hodgkin lymphoma.

Oki Y, Younes A. Oki Y, et al. Among authors: younes a. Leuk Lymphoma. 2008 May;49(5):883-9. doi: 10.1080/10428190801911704. Leuk Lymphoma. 2008. PMID: 18452104 Review.

2

Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma.

Sarris AH, Majlis A, Dimopoulos MA, Younes A, Swann F, Rodriguez MA, McLaughlin P, Cabanillas F. Sarris AH, et al. Among authors: younes a. Leuk Lymphoma. 1995 May;17(5-6):473-7. doi: 10.3109/10428199509056860. Leuk Lymphoma. 1995. PMID: 7549840 Review.

3

Chromosome 17 numerical abnormalities in 55 patients with non-Hodgkin's lymphoma: a fluorescence in situ hybridization study.

Jendiroba D, Younes A, Katz R, Hill D, Cabanillas F, Andreeff M. Jendiroba D, et al. Among authors: younes a. Leukemia. 1995 Jul;9(7):1144-6. Leukemia. 1995. PMID: 7630187

4

Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.

Touroutoglou N, Dimopoulos MA, Younes A, Hess M, Pugh W, Cox J, Cabanillas F, Sarris AH. Touroutoglou N, et al. Among authors: younes a. J Clin Oncol. 1995 Jun;13(6):1361-7. doi: 10.1200/JCO.1995.13.6.1361. J Clin Oncol. 1995. PMID: 7751880

5

Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.

Sarris AH, Younes A, McLaughlin P, Moore D, Hagemeister F, Swan F, Rodriguez MA, Romaguera J, North L, Mansfield P, Callendar D, Mesina O, Cabanillas F. Sarris AH, et al. Among authors: younes a. J Clin Oncol. 1996 Jan;14(1):233-9. doi: 10.1200/JCO.1996.14.1.233. J Clin Oncol. 1996. PMID: 8558203 Clinical Trial.

6

Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study.

Moore DF, Swan F, Yau J, Rodriguez MA, McLaughlin P, Sarris A, Romaguera J, Younes A, Hagemeister FB, Cabanillas F. Moore DF, et al. Among authors: younes a. Clin Oncol (R Coll Radiol). 1995;7(5):300-3. doi: 10.1016/s0936-6555(05)80537-0. Clin Oncol (R Coll Radiol). 1995. PMID: 8580055 Clinical Trial.

7

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.

McLaughlin P, Hagemeister FB, Romaguera JE, Sarris AH, Pate O, Younes A, Swan F, Keating M, Cabanillas F. McLaughlin P, et al. Among authors: younes a. J Clin Oncol. 1996 Apr;14(4):1262-8. doi: 10.1200/JCO.1996.14.4.1262. J Clin Oncol. 1996. PMID: 8648382 Clinical Trial.

8

Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial.

Younes A, Ayoub JP, Sarris A, Hagemeister F, North L, Pate O, McLaughlin P, Rodriguez MA, Romaguera J, Kurzrock R, Preti A, Bachier C, Smith T, Cabanillas F. Younes A, et al. Br J Haematol. 1997 Feb;96(2):328-32. doi: 10.1046/j.1365-2141.1997.d01-2012.x. Br J Haematol. 1997. PMID: 9029021 Free article. Clinical Trial.

9

In vitro and in vivo biologic effects of interleukin-3 (IL-3) in follicular low-grade lymphoma.

Shade RJ, Younes A. Shade RJ, et al. Among authors: younes a. Leuk Lymphoma. 1997 Jun;26(1-2):17-25. doi: 10.3109/10428199709109153. Leuk Lymphoma. 1997. PMID: 9250783 Clinical Trial.

10

Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma.

Younes A, Rodriguez MA, McLaughlin P, North L, Sarris AH, Pate O, Hagemeister FB, Romaguera J, Preti A, Bachier C, Cabanillas F. Younes A, et al. Leuk Lymphoma. 1997 Jun;26(1-2):77-82. doi: 10.3109/10428199709109160. Leuk Lymphoma. 1997. PMID: 9250790 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

750 results

Search Page

Filters